EDRH
ITCI

Edmond de Rothschild Holding’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Edmond de Rothschild Holding’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-27,480
Closed -$1.1M – 886
2015
Q3 		$1.1M Sell
27,480
-22,520
-45% -$734K 0.03% 272
2015
Q2 		$1.6M Buy
+50,000
New +$1.27M 0.03% 241

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Edmond de Rothschild Holding's ITCI Position: Q4 2015 in Review

Edmond de Rothschild Holding sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2015, closing a stake of 27,480 shares — an estimated $1.1M sold.

Edmond de Rothschild Holding first reported a position in ITCI in Q2 2015 and held it in 2 quarters. The position peaked at $1.6M in Q2 2015. 132 funds tracked by Wall St. Rank hold ITCI as of Q4 2015.

  • Edmond de Rothschild Holding reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2015 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 27,480 Intra-Cellular Therapies Inc. shares in Q4 2015, an estimated $1.1M.
  • Edmond de Rothschild Holding first reported a position in Intra-Cellular Therapies Inc. in Q2 2015 and held it in 2 quarters.
  • Edmond de Rothschild Holding's Intra-Cellular Therapies Inc. position peaked at $1.6M in Q2 2015.
  • 132 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2015.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2015, filed 16 Feb 2016.